Journals / Türk Geriatri Dergisi / 2012 / Cilt: 15 - Sayı: 4

The value of s100b proteın measurement for the dıfferentıal dıagnosıs of acute ıschemıc stroke ın the gerıatrıc populatıon

Geriatrik hasta grubunda akut iskemik inme ayırıcı tanısında s-100b protein ölçümünün değeri

Pages
378–384
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The ROC analysis demonstrated that the area under the curve was 0.836 (p= 0.0001).Conclusion: S100B measurement is a rapid, simple and cost-effective analysis which may be used for the differential diagnosis of AIS in the early stages, especially in emergency and intensive care settings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: A blood test supporting the clinical and radiological findings used for the diagnosis of acute ischemic stroke (AIS) is needed in the geriatric population.
📊
Key Findings & Data:The aim was to demonstrate the value of S100B levels for the differential diagnosis of AIS.Materials and Method: 55 patients who have been diagnosed with AIS after admittance to an emergency room and 20 patients with transient ischemic attack (TIA) were enrolled.
💡
Conclusion & Impact:The ROC analysis demonstrated that the area under the curve was 0.836 (p= 0.0001).Conclusion: S100B measurement is a rapid, simple and cost-effective analysis which may be used for the differential diagnosis of AIS in the early stages, especially in emergency and intensive care settings.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: A blood test supporting the clinical and radiological findings used for the diagnosis of acute ischemic stroke (AIS) is needed in the geriatric population. The aim was to demonstrate the value of S100B levels for the differential diagnosis of AIS.Materials and Method: 55 patients who have been diagnosed with AIS after admittance to an emergency room and 20 patients with transient ischemic attack (TIA) were enrolled. AIS diagnosis was based on a neurology consultation in agreement with laboratory and radiological findings. S100B levels were determined in fasting venous blood samples by an ELISA method. The results were expressed as median (minimum-maximum).Results: S100B levels were significantly higher in the AIS group [63.86 (50-1876) pg/ml] than the TIA group [50.14 (< 50- 87.63) pg/ml] (p= 0.001). S100B concentrations were not influenced by age, gender, body mass index or by the presence of coronary artery disease, diabetes mellitus, hyperlipidemia, cardiac arrhythmia, peripheral vascular disease, family history or cigarette smoking. The ROC analysis demonstrated that the area under the curve was 0.836 (p= 0.0001).Conclusion: S100B measurement is a rapid, simple and cost-effective analysis which may be used for the differential diagnosis of AIS in the early stages, especially in emergency and intensive care settings.

Özet

Giriş: Geriatrik populasyon grubunda sıklıkla izlenen akut iskemik inme tanısı için klinik deneyim ve görüntüleme bulgularını destekleyecek bir kan testine ihtiyaç vardır. Bu çalışmada S100B proteinin akut iskemik inme ve geçici iskemik atak ayırıcı tanısındaki değerinin ortaya konması amaçlanmıştır.Gereç ve Yöntem: Çalışmaya Acil Servis'e başvurup, nöroloji konsültasyonu sonucunda klinik bulgular, laboratuvar ve görüntüleme sonuçları birlikte değerlendirilip, akut iskemik inme tanısı alan 55 ve geçici iskemik atak tanılı 20 hasta dahil edilmiştir. Açlık venöz kan örneklerinde ELISA yöntemi ile S100B ölçümü yapılmıştır. Sonuçlar, ortanca (minimum-maksimum) olarak ifade edilmiştir.Bulgular: Akut iskemik inme grubunda [63.86 (50-1876) pg/ml], geçici iskemik atak grubuna [50.14 (

🔖

Cite This Article

BARUTÇUOĞLU, B., KABAROĞLU, C., BAYINDIR, O., BAŞOL, G., UNCU, A., KUMRAL, E., UNCU, G. (2022). The value of s100b proteın measurement for the dıfferentıal dıagnosıs of acute ıschemıc stroke ın the gerıatrıc populatıon. Türk Geriatri Dergisi, Cilt: 15 - Sayı: 4, 378–384. https://ajindex.com/articles/624277

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Jensen MB, Chacon MR, Sattin JA, Levine RL, Vemuganti R. Potential biomarkers for the diagnosis of stroke. Expert Review of Cardiovascular Therapy 2009;7(4):389-93. (PMID:19379063). Easton JD, Saver JL, Albers GW, et al. Definition and evaluati- on of transient ›schemic attack a scientific statement for healt- hcare professionals from the American Heart Association/Ame- rican Stroke Association Stroke Council; Council on Cardiovas- cular Surgery and Anesthesia; Council on Cardiovascular Radio- logy and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke 2009;40:2276-93. (PMID:19423857). 3. Marler JR, Tilley BC, Lu M, Omura T, Yoshida Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55(11):1649-55. (PMID:11113218). 4. Nor AM, Ford GA. Misdiagnosis of stroke. Expert. Rev. Neu- rotherapeutics 2007;7(8):989-1001. (PMID:17678494). 5. Tonarelli SB, Hart RG. What’s new in stroke? The top 10 for 2004/05. J Am Geriatr Soc 2006;54:674–79. (PMID:16686881). 6. Undén J, Strandberg K, Malm J, et al. Explorative investigati- on of biomarkers of brain damage and coagulation system acti- vation in clinical stroke differentiation. J Neurol 2009;256(1):72-7. (PMID:19221847). 7. Turtzo LC, McCullough LD. Sex Differences in Stroke. Cereb- rovasc Dis 2008;26(5): 462–74. (PMID:18810232). 8. Llewellyn DJ, Lang IA, Xie J, Huppert FA, Melzer D, Langa KM. Yoshida Framingham Stroke Risk Profile and poor cogni- tive function: A population-based study. BMC Neurol 2008;8:12. (PMID:18430227). [Internet] Available from: http://www.biomedcentral.com/1471-2377/8/12. Accessed:24.8.2011. 9. Biomarkers Definitions Working Group: Biomarkers and sur- rogate endpoints: Preferred definitions and conceptual frame- work. Clin Pharmacol Ther 2001;69(3):89-95. (PMID:1124097). 10. Tanaka Y, Koizumi C, Marumo T, et al. Serum S100B is a use- ful surrogate marker for long-term outcomes in photochemi- cally-induced thrombotic stroke rat models. Life Sciences 2007;81:657–63. (PMID:17706250). 11. Tanaka Y, Marumo T, Omura T, Yoshida S. Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia. Brain Research 2008;1227:248-54. (PMID:17204253). 12. Kleindienst A, Meissner S, Eyupoglu IY, et al. Dynamics of S100B release into serum and cerebrospinal fluid following acu- te brain injury. Acta Neurochir Suppl. 2010;106:247-50. (PMID:198129